← Eichor
Study identifier: NCT07507422 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

Condition: Chronic Pain · Intractable Pain  ·  Sponsor: Medtronic

PhaseN/A
Planned participants970
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Study Inbox  ·  1-800-633-8766  ·  rs.persiststudy@medtronic.com

Always discuss trial participation with your own doctor first.

Locations (3)

Center for Pain and Supportive CarePhoenix, Arizona, United StatesRecruiting
Christian HospitalSt Louis, Missouri, United StatesRecruiting
North Texas Orthopedics and Spine CenterHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07507422